Prime Medicine, Inc. PRME
4.55 USD +0.11 (+2.48%)
At closeNov 3, 2026, 6:38 PM EST
4.50 -0.05 -1.10%
After hours · Nov 3, 6:38 PM ET
4.44 Day range 4.89
2.67 52-week range 5.91
- YTD
- +31.12%
- 1 year
- -0.22%
Financial health
Altman Z-Score
-5.30 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -2.6×
FY 2019 5y median -4.1× FY 2025
P/S 111×
FY 2019 5y median 0.0× FY 2025
P/B 4.3×
FY 2019 5y median 5.7× FY 2025
P/FCF -3.1×
FY 2019 5y median -4.6× FY 2025
EV/EBITDA -2.9×
FY 2019 5y median -4.2× FY 2025
EV/Sales 123×
FY 2019 5y median 0.0× FY 2025
FCF Yield -32.4%
FY 2019 5y median -21.6% FY 2025
Profitability
Gross Margin -58.1%
FY 2019 5y median 0.0% FY 2025
Operating Margin -4498.1%
FY 2019 5y median 0.0% FY 2025
Net Margin -4342.4%
FY 2019 5y median 0.0% FY 2025
ROE -166.4%
FY 2019 5y median -127.9% FY 2025
ROIC -66.5%
FY 2019 5y median -66.5% FY 2025
ROA -58.7%
FY 2019 5y median -58.7% FY 2025
Growth (YoY)
Revenue 55.3%
FY 2019 FY 2025
Operating Income -2.9%
FY 2019 FY 2025
EPS (diluted) 18.3%
FY 2019 FY 2025
Free Cash Flow -28.4%
FY 2019 FY 2025
Financial Health
Current Ratio 4.8×
FY 2019 5y median 4.8× FY 2025
Quick Ratio 4.8×
FY 2019 5y median 4.8× FY 2025
Debt / Equity 1.0×
FY 2019 5y median 0.1× FY 2025
Net Debt / EBITDA -0.3×
FY 2019 5y median 0.7× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31